
EHA 2020: A new treatment paradigm in relapsed refractory Hodgkin lymphoma
Patients with relapsed/refractory classical Hodgkin lymphoma (R/R cHL) have few treatment options when they are…
Patients with relapsed/refractory classical Hodgkin lymphoma (R/R cHL) have few treatment options when they are…